You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ARQT Sale Disclosure
Welgus Howard G. · SEC Form 4 · Filed Jun 17, 2026
Sale
Calculated transaction value
$16.3K
Welgus Howard G. Director
ARQT
Transaction date
Jun 17, 2026
Public filing date
Jun 17, 2026
Filing lag
Filed same day
ARQT daily price context
Close on/before transaction
$26.22
Jun 17, 2026
First close after public filing
$26.21
Jun 18, 2026
30-day return after filing
+8.7%
Through Jul 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 635 shares @ $25.67
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001628280-26-044079
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$148.76K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc. ARQT Current | Sale | Jun 17, 2026 | $16.3K |
| Arcutis Biotherapeutics, Inc. ARQT | Exercise | Jun 15, 2026 | $7.65K |
| Arcutis Biotherapeutics, Inc. ARQT | Exercise | Jun 15, 2026 | $19.46K |
| Arcutis Biotherapeutics, Inc. ARQT | Sale | Jun 15, 2026 | $99.98K |
| Arcutis Biotherapeutics, Inc. ARQT | Exercise | Jun 15, 2026 | $0 |
| Arcutis Biotherapeutics, Inc. ARQT | Exercise | Jun 15, 2026 | $0 |
| Arcutis Biotherapeutics, Inc. ARQT | Exercise | Jun 15, 2026 | $5.36K |
| Arcutis Biotherapeutics, Inc. ARQT | Exercise | Jun 15, 2026 | $0 |